| http://www.w3.org/ns/prov#value | - We discuss many of these risks, uncertainties and other factors in this Quarterly Report on Form 10-Q under Item 1A ??Risk Factors,?? including risks related to the factors affecting the commercial potential of OMONTYS, the continued safety and efficacy of OMONTYS, the timing of patient accrual in ongoing and planned clinical trials, regulatory requirements, including the U.S. Food and Drug Admini
|
